HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AstraZeneca PLC

http://www.astrazeneca.com

Latest From AstraZeneca PLC

Stock Watch: Beware The Halo Effect Of Biopharma Leaders

Some entrepreneurs combine talent and experience to produce multiple profitable exits for investors. But there are many who do not, and past success is indeed no guarantee of future performance.

Stock Watch Leadership

Collaboration Makes The (Real) World Go Round: Global Efforts Strive To Anchor RWE With Real-World Data Standards And Practices

Can the decentralized global healthcare ecosystem to turn real-world evidence from a buzzword to a useful approach to fit-for-purpose evidence generation?

Real-World Evidence Drug Approval Standards

CinCor Plans Baxdrostat Phase III Despite Phase II Miss In Uncontrolled Hypertension

With subgroup analysis that it claims shows efficacy in non-Hispanics and success in a previous Phase II in treatment-resistant hypertension, CinCor plans to outline Phase III plans to FDA in early 2023.

Clinical Trials Business Strategies

Spectrum Sees Potential Path For Poziotinib In NSCLC Despite Expected CRL

The CRL follows a negative FDA advisory committee vote in September. The company will lay off three-quarters of its R&D force, but sees potential to partner or sell the asset.

Complete Response Letters Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Alexion Pharmaceuticals Inc.
    • Almirall Sofotec
    • AlphaCore Pharma
    • Amplimmune, Inc.
    • Ardea Biosciences, Inc.
    • Arrow Therapeutics
    • Aviron
    • Cellective Therapeutics, Inc.
    • Definiens
    • IntraBiotics Pharmaceuticals, Inc.
    • KuDOS Pharmaceuticals Ltd.
    • Medimmune
    • Novexel
    • Omthera Pharmaceuticals
    • Pearl Therapeutics
    • Spirogen Ltd.
    • U.S. Bioscience
    • Acerta Pharma
    • ZS Pharma
UsernamePublicRestriction

Register